FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Artz

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Andrew S Artz; Koen van Besien
Pre-transplant serum ferritin is prognostic but is it useful?
Nitin Jain; Loren Joseph; Justin Kline; Rangesh Kunnavakkam; Richard A Larson; Hongtao Liu; hector marino; Vu Nguyen; Olatoyosi Odenike; Peter A Savage; Viviane Schouten; Wendy Stock; Jodie Ulaszek; John Anastasi; Andrew S Artz; Lucy A Godley; Amittha Wickrema; Koen van Besien
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
Lori S Muffly; Lisa Pape; Linda Schroeder; Kate Swanson; Koen van Besien; Melissa Boulukos; Paula Del Cerro; Martine Extermann; Masha Kocherginsky; Andrew S Artz
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Artz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrew S Artz; Koen van Besien
Pre-transplant serum ferritin is prognostic but is it useful?
Leukemia & lymphoma 2013;54(6):1133-4.
2013: Nitin Jain; Loren Joseph; Justin Kline; Rangesh Kunnavakkam; Richard A Larson; Hongtao Liu; hector marino; Vu Nguyen; Olatoyosi Odenike; Peter A Savage; Viviane Schouten; Wendy Stock; Jodie Ulaszek; John Anastasi; Andrew S Artz; Lucy A Godley; Amittha Wickrema; Koen van Besien
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
Leukemia & lymphoma 2013;54(6):1242-9.
2013: Lori S Muffly; Lisa Pape; Linda Schroeder; Kate Swanson; Koen van Besien; Melissa Boulukos; Paula Del Cerro; Martine Extermann; Masha Kocherginsky; Andrew S Artz
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):429-34.
2012: Jane E Churpek; Andrew S Artz; Janet Lepore; Bohao Liu; Rachelle Lorenz; Jozef Madzo; Rafael Marquez; Eric Nickels; Katarzyna Rojek; Koen van Besien; Amittha Wickrema; Lucy A Godley
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
Blood 2012;120(26):5247-9.
2012: Rish K Pai; Koen van Besien; Andrew S Artz; John Hart; Peter H O'Donnell
Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.
Leukemia & lymphoma 2012;53(8):1552-7.
2012: Elie M Richa; Wendy Stock; Amittha Wickrema; Koen Van Besien; Lucy A Godley; Justin Kline; Rangesh Kunnavakkam; Richard A Larson; Vu Nguyen; Olatoyosi Odenike; Andrew S Artz
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
Cytotherapy 2012;14(6):707-15.
2012: Koen van Besien; Paula Del Cerro; Lucy A Godley; Justin Kline; Richard A Larson; Vu Nguyen; Olatoyosi Odenike; Peter H O'Donnell; Elizabeth Rich; Wendy Stock; Andrew S Artz
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):913-21.
2012: Sarah M Larson; Olatoyosi Odenike; Dorothy Sipkins; Michael J Thirman; Koen van Besien; Howie Weiner; Yanming Zhang; Andrew S Artz; Nicholas P Campbell; Christopher Daugherty; Devika Gajria; Lucy A Godley; Margaret Green; Sandeep Gurbuxani; Dezheng Huo; Elizabeth Hyjek; Richard A Larson; Wendy Stock
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
Leukemia & lymphoma 2012;53(3):445-50.
2012: Andrew S Artz
From biology to clinical practice: aging and hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(1 Suppl):S40-5.
2011: Andrew S Artz; Michael J Thirman
Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic.
The journals of gerontology. Series A, Biological sciences and medical sciences 2011;66(8):925-32.
2011: Olatoyosi Odenike; Michael J Thirman; Andrew S Artz; Lucy A Godley; Richard A Larson; Wendy Stock
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
Seminars in oncology 2011;38(2):196-214.
2011: Vaishalee P Kenkre; Sarah Horowitz; Andrew S Artz; Chuanhong Liao; Kenneth S Cohen; Lucy A Godley; Justin P Kline; Sonali M Smith; Wendy Stock; Koen van Besien
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
Leukemia & lymphoma 2011;52(2):214-22.
2011: Hongtao Liu; Andrew S Artz
Reduction of imatinib absorption after gastric bypass surgery.
Leukemia & lymphoma 2011;52(2):310-3.
2010: F L Locke; Andrew S Artz; Elizabeth Rich; Y Zhang; Koen van Besien; Wendy Stock
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.
Bone marrow transplantation 2010;45(12):1692-8.
2010: Lucy A Godley; Uchenna O Njiaju; Margaret Green; Howard Weiner; Shang Lin; Olatoyosi Odenike; Elizabeth Rich; Andrew S Artz; Koen van Besien; Christopher K Daugherty; Yanming Zhang; Michelle M Le Beau; Wendy Stock; Richard A Larson
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
Leukemia & lymphoma 2010;51(6):995-1006.
2009: Koen van Besien; Alexander Dew; Shang Lin; Loren Joseph; Lucy A Godley; Richard A Larson; Toyosi Odenike; Elizabeth Rich; Wendy Stock; Amittha Wickrema; Andrew S Artz
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
Leukemia & lymphoma 2009;50(11):1809-17.
2009: Peter H O'Donnell; Kate Swanson; Michelle A Josephson; Andrew S Artz; Sandeep D Parsad; Charulata Ramaprasad; Kenneth Pursell; Elizabeth Rich; Wendy Stock; Koen van Besien
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1038-1048.e1.
2009: Koen van Besien; Rangesh Kunavakkam; Gaby Rondon; Marcos De Lima; Andrew S Artz; Betul Oran; Sergio Giralt
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):610-7.
2009: Xavier Poiré; Andrew S Artz; Richard A Larson; Justin Kline; Olatoyosi Odenike; Elizabeth Rich; Lucy A Godley; Wendy Stock; Koen van Besien
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
Leukemia & lymphoma 2009;50(1):85-91.
2008: Andrew S Artz; Amittha Wickrema; Shira Dinner; Lucy A Godley; Masha Kocherginsky; Olatoyosi Odenike; Elizabeth Rich; Wendy Stock; Jodie Ulaszek; Richard A Larson; Koen van Besien
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1209-16.
2008: Andrew S Artz
Anemia and the frail elderly.
Seminars in hematology 2008;45(4):261-6.
2008: Alexander Dew; Demetria Collins; Andrew S Artz; Elizabeth Rich; Wendy Stock; Kate Swanson; Koen van Besien
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):938-41.
2008: Melinda K. Gordon; Dorie A Sher; Theodore Karrison; Partow Kebriaei; Karen Chuang; Yanming Zhang; Diane McDonnell; Andrew S Artz; Lucy A Godley; Olatoyosi Odenike; Elizabeth Rich; Laura Michaelis; Michael J Thirman; Amittha Wickrema; Koen van Besien; Richard A Larson; Wendy Stock
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
Leukemia & lymphoma 2008;49(3):531-7.
2008: Andrew S Artz; David Pitrak
Separating correlation from prediction: C-reactive protein and infectious complications after chemotherapy for acute myeloid leukemia.
Leukemia & lymphoma 2008;49(3):381-2.
2007: Daniel A Pollyea; Andrew S Artz; Wendy Stock; Christopher K Daugherty; Lucy A Godley; Olatoyosi Odenike; Elizabeth Rich; S M Smith; Todd M Zimmerman; Y Zhang; Dezheng Huo; R Larson; Koen van Besien
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2007;40(11):1027-32.
2007: Brian T Hill; Lavayna Kondapalli; Andrew S Artz; Sonali Smith; Elizabeth Rich; Lucy A Godley; Olatoyosi Odenike; Kenneth Pursell; Richard A Larson; Wendy Stock; Koen van Besien
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
Leukemia & lymphoma 2007;48(9):1799-805.
2007: L Michaelis; S Lin; L Joseph; Andrew S Artz; J Kline; Daniel A Pollyea; Wendy Stock; Elizabeth Rich; D Collins-Jones; B Casey; P Del Cerro; Koen van Besien
Chimerism does not predict for outcome after alemtuzumab based conditioning.
Bone marrow transplantation 2007;40(2):181.
2006: Andrew S Artz; Daniel A Pollyea; Masha Kocherginsky; Wendy Stock; Elizabeth Rich; Olatoyosi Odenike; Todd M Zimmerman; Sonali Smith; Lucy A Godley; Michael J Thirman; Christopher K Daugherty; Martine Extermann; Richard Larson; Koen van Besien
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):954-64.
2006: J Kline; Koen van Besien; J Nathanson; A Noffsinger; Andrew S Artz
Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
Bone marrow transplantation 2006;38(5):391-2.
2006: Andrew S Artz; Masha Kocherginsky; Koen van Besien
Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2006;132(6):747-54.
2006: J Kline; Daniel A Pollyea; Wendy Stock; Andrew S Artz; Elizabeth Rich; Lucy A Godley; Todd M Zimmerman; Kenneth Thompson; Kenneth Pursell; Richard A Larson; Koen van Besien
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Bone marrow transplantation 2006;37(3):307-10.
2005: Koen van Besien; Andrew S Artz; Sonali Smith; D Cao; S Rich; Lucy A Godley; D Jones; P Del Cerro; D Bennett; B Casey; Olatoyosi Odenike; Michael J Thirman; Christopher K Daugherty; Amittha Wickrema; Todd M Zimmerman; Richard A Larson; Wendy Stock
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5728-38.
2005: Andrew S Artz; Walter M Stadler; Nicholas J Vogelzang; Todd M Zimmerman; Christopher W Ryan
A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
American journal of clinical oncology 2005;28(2):109-13.
2005: Andrew S Artz; Koen van Besien; Todd M Zimmerman; Thomas F Gajewski; B I Rini; H S Hu; Walter M Stadler; Nicholas J Vogelzang
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
Bone marrow transplantation 2005;35(3):253-60.
2005: Koen van Besien; Andrew S Artz; Wendy Stock
Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?
Leukemia 2005;19(1):31-3.
2004: Helena Harlin; Andrew S Artz; Mary Mahowald; B I Rini; Todd M Zimmerman; Nicholas J Vogelzang; Thomas F Gajewski
Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
Bone marrow transplantation 2004;33(5):491-7.